Skip to main content

Table 1 Correlations between IL-34, MCSF and CD68+ TAMs and clinical pathological features in patients with GC (n = 180)

From: Inverse correlation between Interleukin-34 and gastric cancer, a potential biomarker for prognosis

Characteristics Patients IL-34 CD68 MCSF
Median p Median p Median p
All cancer 180 33,827 < 0.001 1366 < 0.001 36.61 < 0.001
Noncancer (non) 159 57,921 246.0 1007
Gender
 Male 140 37,935 0.030 1325 > 0.999 38.02 > 0.999
 Female 40 14,847 1535 27.25
Age
 ≤ 60 79 20,658 0.048 1066 0.083 25.53 0.742
 > 60 101 38,759 1702 48.79
Tumour size (diameter)
 < 5 cm 87 40,818 0.358 1418 > 0.999 45.35 > 0.999
 ≥ 5 cm 93 24,419 1321 32.54
Lymph node metastasis
 No 75 43,296 > 0.999 1715 0.169 48.20 > 0.999
 Yes 105 30,495 1185 28.30
Differentiation
 High 14 78,613 H/L: 0.043
H/M: 0.499
M/L: 0.495
1250 All > 0.999 223.8 H/L: 0.051
H/M: 0.471
M/L: 0.791
 Moderate 78 39,376 1757 40.12
 Low 88 20,788 1186 26.00
Tumour invasion depth
 T1 4 87,693 All > 0.999 1762 All > 0.999 20.82 All > 0.999
 T2 27 51,850 1644 26.86
 T3 75 27,518 1593 40.12
 T4 74 32,160 1101 39.80
TNM
 I 12 22,371 I/II, I/III
I/IV, II/III
> 0.999
II/IV: 0.278
III/IV: 0.643
1644 I/II, I/III
I/IV, II/IV III/IV
> 0.999
II/III: 0.636
27.25 I/II, I/III
II/III > 0.999
I/IV: 0.942
II/IV: 0.277
III/IV: 0.183
 II 70 42,580 1564 48.79
 III 92 32,051 1147 42.15
 IV 6 6544 936.6 3.390